Literature DB >> 3300589

Xerostomia. A neglected symptom.

L M Sreebny, A Valdini.   

Abstract

Xerostomia, the subjective feeling of dry mouth caused by a severe reduction in the flow of saliva, is a common problem that is particularly prevalent among the aged. It has become increasingly evident that dry mouth is associated with a number of serious systemic conditions and diseases. Among these are the intake of commonly prescribed medications, autoimmune diseases, and irradiation to the head and neck. The diminution in the flow of saliva may profoundly affect oral health, disturb digestion and speech, and seriously impair the patient's quality of life. Food avoidance, nonabsorption of sublingually placed drugs, and noncompliance with medication may also result. Sialometry can be used to confirm the presence of dry mouth. Treatment is aimed at increasing the flow of saliva, when possible, or providing oral moisture by other means.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3300589     DOI: 10.1001/archinte.147.7.1333

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  41 in total

1.  Clinical diagnosis of hyposalivation in hospitalized patients.

Authors:  Soraya de Azambuja Berti-Couto; Paulo Henrique Couto-Souza; Reinhilde Jacobs; Olivia Nackaerts; Izabel Regina Fischer Rubira-Bullen; Fernando Henrique Westphalen; Samuel Jorge Moysés; Sérgio Aparecido Ignácio; Maitê Barroso da Costa; Ana Lúcia Tolazzi
Journal:  J Appl Oral Sci       Date:  2012 Mar-Apr       Impact factor: 2.698

2.  Factors associated with oral hygiene practices among adults with systemic sclerosis.

Authors:  H K Yuen; F N Hant; C Hatfield; L M Summerlin; E A Smith; R M Silver
Journal:  Int J Dent Hyg       Date:  2013-10-15       Impact factor: 2.477

3.  An innovative design of 2-piece saliva reservoir using precision attachment: a case report.

Authors:  Modgi Chetan Mukund; Aras Meena Ajay
Journal:  J Indian Prosthodont Soc       Date:  2012-06-28

4.  Targeted immobilisation of lysozyme in the enamel pellicle from different solutions.

Authors:  Christian Hannig; Bettina Spitzmüller; Wiebke Hoth-Hannig; Matthias Hannig
Journal:  Clin Oral Investig       Date:  2009-12-05       Impact factor: 3.573

Review 5.  World Workshop on Oral Medicine VI: a systematic review of medication-induced salivary gland dysfunction: prevalence, diagnosis, and treatment.

Authors:  Alessandro Villa; Andy Wolff; Doron Aframian; Arjan Vissink; Jörgen Ekström; Gordon Proctor; Richard McGowan; Nagamani Narayana; Ardita Aliko; Ying Wai Sia; Revan Kumar Joshi; Siri Beier Jensen; Alexander Ross Kerr; Colin Dawes; Anne Marie Lynge Pedersen
Journal:  Clin Oral Investig       Date:  2015-05-22       Impact factor: 3.573

6.  Modification of the tear function index and its use in the diagnosis of Sjögren's syndrome.

Authors:  S B Kaye; G Sims; C Willoughby; A E Field; L Longman; M C Brown
Journal:  Br J Ophthalmol       Date:  2001-02       Impact factor: 4.638

7.  Efficacy of pastes containing CPP-ACP and CPP-ACFP in patients with Sjögren's syndrome.

Authors:  Tamara Peric; Dejan Markovic; Bojan Petrovic; Vesna Radojevic; Tatjana Todorovic; Biljana Andjelski Radicevic; Radmila Jancic Heinemann; Gordana Susic; Aleksandra Peric Popadic; Vesna Tomic Spiric
Journal:  Clin Oral Investig       Date:  2015-03-13       Impact factor: 3.573

Review 8.  Oral pilocarpine: a review of its pharmacological properties and clinical potential in xerostomia.

Authors:  L R Wiseman; D Faulds
Journal:  Drugs       Date:  1995-01       Impact factor: 9.546

9.  Factors associated with gingival inflammation among adults with systemic sclerosis.

Authors:  H K Yuen; Y Weng; S G Reed; L M Summerlin; R M Silver
Journal:  Int J Dent Hyg       Date:  2013-04-24       Impact factor: 2.477

10.  Management of xerostomia in older patients : a randomised controlled trial evaluating the efficacy of a new oral lubricant solution.

Authors:  Stéphane Mouly; Michel Salom; Yves Tillet; Anne-Claude Coudert; Frantz Oberli; Philip M Preshaw; Stéphane Desjonquères; Jean-François Bergmann
Journal:  Drugs Aging       Date:  2007       Impact factor: 3.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.